help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on September 28, 2005, doi:10.1164/rccm.200504-546OC

Am. J. Respir. Crit. Care Med., Volume 172, Number 12, December 2005, 1581-1585

A more recent version of this article appeared on December 15, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200504-546OCv1
172/12/1581    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henke-Gendo, C.
Right arrow Articles by Schulz, T. F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henke-Gendo, C.
Right arrow Articles by Schulz, T. F

Submitted on April 8, 2005
Accepted on September 27, 2005

Absence of Kaposi's Sarcoma-associated Herpesvirus in Patients with Pulmonary Arterial Hypertension

Cornelia Henke-Gendo1, Michael Mengel2, Marius M Hoeper3, Khaled Alkharsah1, and Thomas F Schulz1*

1 Institute of Virology, Hannover Medical School, Hannover, Germany, 2 Institute of Pathology, Hannover Medical School, Hannover, Germany, 3 Department of Pulmonary Medicine, Hannover Medical School, Hannover, Germany

* To whom correspondence should be addressed. E-mail: Schulz.thomas{at}mh-hannover.de.

Rationale: In addition to Kaposi's sarcoma, Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) has been associated with two other diseases, primary effusion lymphoma and the plasma cell variant of multicentric Castleman's disease. Recently, evidence of KSHV infection was reported in plexiform lesions of idiopathic pulmonary arterial hypertension (IPAH) as well as in adjacent parenchyma and bronchial epithelial cells. Objectives: To further investigate a possible association of KSHV and pulmonary arterial hypertension. Methods and measurements: Twenty-six lungs explanted from German patients suffering from IPAH were tested for the presence of KSHV antigen and genomes by immunohistochemistry (IHC) and PCR. Main Results: When stained with a commercial monoclonal antibody directed against the latency-associated nuclear antigen of KSHV, LANA-1, a positive signal reminiscent of the "speckled" nuclear pattern typical for latently KSHV-infected cells was found in 16 (61.5%) cases. Alveolar and bronchial epithelial cells in areas of unremarkable lung tissue, but not cells within the plexiform lesions were the predominantly stained cell types. Different KSHV-PCR assays (based on orf 26, orf K6 and orf 72) performed on samples that had tested positively in IHC, however, could not confirm KSHV infection, indicating that the IHC-signal was not due to KSHV infection. One IHC-negative patient tested positive by PCR. A PCR based on consensus degenerate hybrid oligonucleotide primers (CODEHOP) to detect yet unknown {gamma}-herpesviruses did not reveal any specific sequences. Conclusions: KSHV is unlikely to play a role in the pathogenesis of idiopathic pulmonary arterial hypertension.


Key words: etiology, pathogenesis, CODEHOP




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
P. M. Hassoun, L. Mouthon, J. A. Barbera, S. Eddahibi, S. C. Flores, F. Grimminger, P. L. Jones, M. L. Maitland, E. D. Michelakis, N. W. Morrell, et al.
Inflammation, growth factors, and pulmonary vascular remodeling.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S10 - S19.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
T. M. Bull, C. A. Meadows, C. D. Coldren, M. Moore, S. M. Sotto-Santiago, S. P. Nana-Sinkam, T. B. Campbell, and M. W. Geraci
Human Herpesvirus-8 Infection of Primary Pulmonary Microvascular Endothelial Cells
Am. J. Respir. Cell Mol. Biol., December 1, 2008; 39(6): 706 - 716.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Butrous, H. A. Ghofrani, and F. Grimminger
Pulmonary Vascular Disease in the Developing World
Circulation, October 21, 2008; 118(17): 1758 - 1766.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Humbert and M. M. Hoeper
Severe Pulmonary Arterial Hypertension: A Forme Fruste of Cancer?
Am. J. Respir. Crit. Care Med., September 15, 2008; 178(6): 551 - 552.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. A. Ghofrani, R. Voswinckel, F. Reichenberger, N. Weissmann, R. T. Schermuly, W. Seeger, and F. Grimminger
Hypoxia- and non-hypoxia-related pulmonary hypertension - Established and new therapies
Cardiovasc Res, October 1, 2006; 72(1): 30 - 40.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. M. Hoeper and L. J. Rubin
Update in pulmonary hypertension 2005.
Am. J. Respir. Crit. Care Med., March 1, 2006; 173(5): 499 - 505.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
H. Katano and C. M. Hogaboam
Herpesvirus-associated Pulmonary Hypertension?
Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1485 - 1486.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society
  ATS 2008 State of the Art Course